EQUITY - Disclosure of changes in issued and outstanding share capital (Details) |
6 Months Ended | |||
|---|---|---|---|---|
|
Jun. 30, 2022
shares
| ||||
| Disclosure of classes of share capital [line items] | ||||
| Common Shares issued in settlement of purchase consideration of a business combination | 1,260,063 | [1] | ||
| Beginning Balance | 68,217,894 | |||
| Common Shares issued as a result of options exercises | 217,368 | |||
| Ending Balance | 69,695,325 | |||
| Pharm Yarok | ||||
| Disclosure of classes of share capital [line items] | ||||
| Common Shares issued in settlement of purchase consideration of a business combination | 523,700 | [1] | ||
| Vironna | ||||
| Disclosure of classes of share capital [line items] | ||||
| Common Shares issued in settlement of purchase consideration of a business combination | 485,362 | [1] | ||
| Oranim | ||||
| Disclosure of classes of share capital [line items] | ||||
| Common Shares issued in settlement of purchase consideration of a business combination | 251,001 | [1] | ||
| ||||
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued in business combination transaction. No definition available.
|
| X | ||||||||||
- Definition Information about ordinary shares issued as a result of options exercises. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|